These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 25215932)

  • 1. Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion.
    Ashour AA; Gurbuz N; Alpay SN; Abdel-Aziz AA; Mansour AM; Huo L; Ozpolat B
    J Cell Mol Med; 2014 Nov; 18(11):2235-51. PubMed ID: 25215932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells.
    Ashour AA; Abdel-Aziz AA; Mansour AM; Alpay SN; Huo L; Ozpolat B
    Apoptosis; 2014 Jan; 19(1):241-58. PubMed ID: 24193916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cells.
    Gurbuz N; Ashour AA; Alpay SN; Ozpolat B
    PLoS One; 2014; 9(9):e110067. PubMed ID: 25268648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elongation factor-2 kinase (eEF-2K) expression is associated with poor patient survival and promotes proliferation, invasion and tumor growth of lung cancer.
    Bircan HA; Gurbuz N; Pataer A; Caner A; Kahraman N; Bayraktar E; Bayraktar R; Erdogan MA; Kabil N; Ozpolat B
    Lung Cancer; 2018 Oct; 124():31-39. PubMed ID: 30268477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cells.
    Gurbuz N; Ashour AA; Alpay SN; Ozpolat B
    PLoS One; 2014; 9(8):e105245. PubMed ID: 25170871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
    Kabil N; Bayraktar R; Kahraman N; Mokhlis HA; Calin GA; Lopez-Berestein G; Ozpolat B
    Breast Cancer Res Treat; 2018 Oct; 171(3):593-605. PubMed ID: 29971628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer.
    Tekedereli I; Alpay SN; Tavares CD; Cobanoglu ZE; Kaoud TS; Sahin I; Sood AK; Lopez-Berestein G; Dalby KN; Ozpolat B
    PLoS One; 2012; 7(7):e41171. PubMed ID: 22911754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.
    He X; Zheng Z; Li J; Ben Q; Liu J; Zhang J; Ji J; Yu B; Chen X; Su L; Zhou L; Liu B; Yuan Y
    Carcinogenesis; 2012 Mar; 33(3):555-62. PubMed ID: 22223849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells.
    Ahmed N; Oliva K; Wang Y; Quinn M; Rice G
    Br J Cancer; 2003 Jul; 89(2):374-84. PubMed ID: 12865932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system.
    Huang C; Xie D; Cui J; Li Q; Gao Y; Xie K
    Clin Cancer Res; 2014 Mar; 20(6):1477-88. PubMed ID: 24452790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the impact of eukaryotic elongation factor 2 kinase on cancer: A systematic review.
    Li S; Li Y; Bai Y
    Eur J Pharmacol; 2019 Aug; 857():172470. PubMed ID: 31226250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells.
    Lin CY; Tsai PH; Kandaswami CC; Chang GD; Cheng CH; Huang CJ; Lee PP; Hwang JJ; Lee MT
    Mol Cancer; 2011 Jul; 10():87. PubMed ID: 21777419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue transglutaminase inhibits autophagy in pancreatic cancer cells.
    Akar U; Ozpolat B; Mehta K; Fok J; Kondo Y; Lopez-Berestein G
    Mol Cancer Res; 2007 Mar; 5(3):241-9. PubMed ID: 17374730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA-193b-5p Suppresses Pancreatic Cancer Cell Proliferation, Invasion, Epithelial Mesenchymal Transition, and Tumor Growth by Inhibiting eEF2K.
    Gurbuz N; Kahraman N; Sonmez HE; Mokhlis HA; Kosar PA; Ozpolat B
    Anticancer Agents Med Chem; 2022; 22(14):2607-2618. PubMed ID: 35718922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel compounds, '1,3-selenazine derivatives' as specific inhibitors of eukaryotic elongation factor-2 kinase.
    Cho SI; Koketsu M; Ishihara H; Matsushita M; Nairn AC; Fukazawa H; Uehara Y
    Biochim Biophys Acta; 2000 Jul; 1475(3):207-15. PubMed ID: 10913818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the complex between calmodulin and a functional construct of eukaryotic elongation factor 2 kinase bound to an ATP-competitive inhibitor.
    Piserchio A; Isiorho EA; Dalby KN; Ghose R
    J Biol Chem; 2023 Jun; 299(6):104813. PubMed ID: 37172726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular mechanism of eukaryotic elongation factor 2 kinase activation.
    Tavares CD; Ferguson SB; Giles DH; Wang Q; Wellmann RM; O'Brien JP; Warthaka M; Brodbelt JS; Ren P; Dalby KN
    J Biol Chem; 2014 Aug; 289(34):23901-16. PubMed ID: 25012662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting eukaryotic elongation factor-2 kinase suppresses the growth and peritoneal metastasis of ovarian cancer.
    Erdogan MA; Ashour A; Yuca E; Gorgulu K; Ozpolat B
    Cell Signal; 2021 May; 81():109938. PubMed ID: 33539938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.